Westlake Chemical Partners LP Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.2B+8.7% YoYTTM through 30 Jun 2026
Net Income $57.6M-7.7% YoYTTM through 30 Jun 2026
Free Cash Flow $409.1MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 30.7% |
| EBITDA Margin | 40.0% |
| Operating Margin | 28.3% |
| Net Margin | 4.7% |
Returns
22.6%ROE
27.3%ROA
51.4%ROIC
Balance Sheet Health
Debt / Equity1.56x
Current Ratio3.65x
Net Debt$318.9M
Cash & Equivalents$49.3M
Quality Metrics
Piotroski F-Score5 / 9
FCF Margin33.1%
Rule of 4043.9
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $1.2B
Diluted EPSFY2015: $1.47
Dividend
$0.94Per share, FY20264.41%Yield-12.9%5-yr growth
Capital Allocation
Capex Intensity4.6%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.